ASN-002

· Ascend Biopharmaceuticals Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ASN-002, covering 2018-06-06 to 2024-04-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor [Phase 2]